Janssen Scientific Affairs, LLC, a member of the Johnson & Johnson Family of Companies, is recruiting for a Principal Research Scientist (Associate Director), US Medical Affairs, Oncology (Hematologic Malignancies), located in Horsham, PA.
At the Janssen Pharmaceutical Companies of Johnson & Johnson, what matters most is helping people live full and healthy lives. We focus on treating, curing and preventing some of the most devastating and complex diseases of our time. And we pursue the most promising science, wherever it might be found.
Janssen Scientific Affairs, LLC is dedicated to providing medical information and consultative support to the Janssen pharmaceutical companies.
Janssen Pharmaceuticals, Inc. provides medicines for an array of health concerns in several therapeutic areas, including Cardiovascular, Metabolic, Mental Health, and Pain Management. Please visit www.JanssenPharmaceuticalsInc.com for more information.
We are Janssen. Our mission drives us. Our patients inspire us. We collaborate with the world for the health of everyone in it.
The Principal Research Scientist will report to the Therapeutic Area Lead for Hematologic Malignancies in US Medical Affairs and will:
• Focus on research scientific support for company sponsored MA led interventional and observational clinical trials.
• Assist the Study Responsible Physician (SRP) and work with clinical operations and other functions to develop company sponsored protocols and eCRFs.
• Monitor, review and analyze clinical trial data, assist with investigation and acquisition of additional necessary data for safety reporting, and develop the Clinical Study Report (CSR), abstracts and scholarly publications.
• Provide scientific and strategic support for the Investigator Initiated Study (IIS) program through review of submitted IIS applications, protocols and informed consent forms.
• Establish relationships and communicate with external investigators on both company and investigator sponsored studies, as well as key external scientific and clinical experts.
• Support the development and execution of advisory boards and assist with other evidence generation activities for the Hematologic Malignancies group.